ERBB2 and breast cancer: Interestingly, rutin amplifies chemosensitivity to cyclophosphamide and methotrexate while reversing MDR by suppressing P-gp and BCRP pumps in MB-MDA-231 and MCF-7 cell lines using well-characterized models of TNBC and HER2-negative breast cancer, respectively.